Skip to main content
Clinical Trials/CTRI/2025/07/090732
CTRI/2025/07/090732
Not yet recruiting
Phase 2/3

A RANDOMISED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF KUMARI SIDDHA TAILA MATRABASTI AND SHATPUSHPA SIDDHA TAILA MATRABASTI IN ANOVULATORY CYCLE IN ANOVULATORY CYCLE IN PCOS

Tilak ayurvedic mahavidyalaya rasta peth Pune1 site in 1 country50 target enrollmentStarted: August 1, 2025Last updated:

Overview

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Tilak ayurvedic mahavidyalaya rasta peth Pune
Enrollment
50
Locations
1
Primary Endpoint
The study will analyze the clinical signs and symptoms to determine the effectiveness of each treatment.

Overview

Brief Summary

The study will be intervened by the treatment of Kumari siddha tail matra basti and Shatpushpa siddha taila matra basti to group A and group B respectively. The efficacy of the

therapy will be assessed on the basis of subjective and objective criteria for statistical

analysis. Scoring will be designed according to the severity of symptoms. The

subjective and objective gradation of symptoms will be done as follows and the

intensity of each symptom will be calculated before treatment, after treatment and

after follow up. The effect of treatment result will be assessed in regards to clinical

signs and symptoms on the basis of grading and scoring system. The signs and

symptoms will be assessed by adopting the suitable scoring method.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 35.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Age group 18-35 years.
  • Diagnosis Ultrasound Polycystic ovarian morphology.
  • Diagnosed cases of PCOS with any of the following symptoms Ovulatory dysfunction refers to Oligomenorrhea or amenorrhea.
  • Anovulatory Cycles Irregular Menses/ Scanty Menses.
  • Hirsutism Obesity Acanthosis Nigricans.

Exclusion Criteria

  • Patients having history of Systemic diseases like Diebetes mellitus, Hypertension, etc.
  • Irregular menses due to anatomical defect in reproductive system such as Hypoplastic Uterus, Aplastic Uterus, Streak Ovaries, Hypogonadism.
  • Menorrhagia in PCOS.

Outcomes

Primary Outcomes

The study will analyze the clinical signs and symptoms to determine the effectiveness of each treatment.

Time Frame: 12 weeks

Secondary Outcomes

  • No any(No ANY)

Investigators

Sponsor
Tilak ayurvedic mahavidyalaya rasta peth Pune
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

DrSampada Anil Shinde

Tilak ayurvedic mahavidyalaya rasta peth pune

Study Sites (1)

Loading locations...

Similar Trials